Clinical Nurse Specialist Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ladema Gallagher

Psychiatry Lebanon, IN Clinical Nurse Specialist

NPI 1912089558 CMS profile 3542152

2605 N Lebanon St, Lebanon, IN 46052

Open in the dashboard

General payments

$4,981

273 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ladema Gallagher of Lebanon, IN is reported in the CMS Open Payments database as having received $4,981 across 273 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,708 89
2024 General $1,247 78
2023 General $1,956 102
2022 General $41 2
2021 General $29 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ladema Gallagher
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Ladema Gallagher were reported at $1,708. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Ladema Gallagher Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $29 $143 $43–$576 $132
2022 $41 $153 $50–$590 $149
2023 $1,956 $170 $56–$651 $160
2024 $1,247 $179 $57–$673 $164
2025 $1,708 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ITI, Inc. $796 53 payments
  2. AbbVie, Inc. $705 48 payments
  3. Vanda Pharmaceuticals Inc. $556 24 payments
  4. Corium, Inc. $519 31 payments
  5. Otsuka America Pharmaceutical, Inc. $503 23 payments
  6. Axsome Therapeutics, Inc. $459 17 payments
  7. Ironshore Pharmaceuticals Inc. $199 16 payments
  8. Lundbeck LLC $164 8 payments
  9. Neos Therapeutics, LP $164 10 payments
  10. Noven Therapeutics, LLC $125 7 payments
  11. Other $790 36 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,981 273 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $661 46 payments
  2. HETLIOZ $556 24 payments
  3. FANAPT $556 24 payments
  4. Azstarys $519 31 payments
  5. CAPLYTA Psychiatry $512 30 payments
  6. Auvelity $444 16 payments
  7. REXULTI $435 17 payments
  8. CAPLYTA Psychiatry $283 23 payments
  9. JORNAY PM $199 16 payments
  10. Adzenys XR-ODT $164 10 payments
  11. Other $1,674 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 20 drugs

Part D claims

506

Median for Certified Clinical Nurse Specialist: 344

Drug cost

$31,594

Median for Certified Clinical Nurse Specialist: $20,739

Branded share of claims

23.9%

Median for Certified Clinical Nurse Specialist: 20.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Vraylar Cariprazine Hcl Brand 13 $18,580
Trintellix Vortioxetine Hydrobromide Brand 13 $5,857
Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine Brand 28 $1,208
Bupropion Xl Bupropion Hcl Brand 33 $1,083
Escitalopram Oxalate Generic 57 $957
Aripiprazole Generic 25 $888
Divalproex Sodium Generic 15 $448
Venlafaxine Hcl Er Venlafaxine Hcl Brand 14 $415
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 20 $401
Buspirone Hcl Generic 27 $296

The 10 drugs with the highest cost, of 20 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$6,711

Medicare's payments for the services billed

Medicare patients

19

Average age 63

Services billed

96

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Depression 63%
Arthritis 58%
COPD 0%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 16 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CAPLYTA
  • ITI, Inc. $242
$242 — —
VRAYLAR
  • AbbVie, Inc. $197
$197 13 —
JORNAY PM
  • Ironshore Pharmaceuticals Inc. $185
$185 — —
Azstarys
  • Corium, Inc. $130
$130 — —
REXULTI
  • Otsuka America Pharmaceutical, Inc. $104
  • Lundbeck LLC $15
$119 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 16 in the dashboard with a free account

Records

273 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record